John T. Lucas Jr., MD, MS

As we strive to optimize treatments and provide personalized care for pediatric patients, my work takes a multifactorial approach that spans several areas. My involvement in clinical trials has led to dose de-escalation for patients with high-risk neuroblastoma and the evaluation of proton therapy’s role in acute and late effects in childhood cancer survivors. My partnership with St. Jude Global has led me to consult on global tumor boards and mentor developing pediatric radiation oncologists from across the world, which has significantly expanded my skillset and potential for contribution as a radiation oncologist. 

Dr. John T. Lucas Jr. is a board-certified radiation oncologist with a dedication to pediatric radiation oncology and translational research. As an associate member at St. Jude, Dr. Lucas leverages his expertise in advanced biomolecular techniques, imaging analysis and clinical trial design to offer new interventions and insights in the context of therapeutic and non-therapeutic trails. He also designs complex trials, analyzes rare pediatric tumors and refines treatment/surveillance for late effects in childhood cancer survivors. These pillars of clinical work and research have emboldened Dr. Lucas’s deep passion for childhood cancer patients and have fueled his contributions across the institution, to national cooperative groups and in international global childhood cancer initiatives.